HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases
HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases
Active, not recruiting · NCT03696030 · Registry updated 2026-08-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases | Neoplasms by Site, Skin and Connective Tissue Diseases, brain disorder, breast cancer, breast disorder, breast neoplasm, cancer, central nervous system cancer, central nervous system disorder, metastatic malignant neoplasm in the brain, neoplasm, neoplastic meningitis, nervous system disorder, skin disorder, tumor of meninges | Active, not recruiting | Phase 1 | 2026-08-12 | NCT03696030 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| California Institute for Regenerative Medicine (CIRM) | 36 |
| City of Hope Medical Center | 347 |
| National Cancer Institute (NCI) | 3015 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City of Hope Medical Center | Duarte | United States | 313 |